Extrahepatic Bile Duct Cancer [clinicaltrials_resource:2afb235bda23dfa1a954074da411145c]
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer [clinicaltrials:NCT00003296]Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer [clinicaltrials:NCT00003411]Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]clinicaltrials:NCT00003557Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas [clinicaltrials:NCT00003923]clinicaltrials:NCT00004604Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [clinicaltrials:NCT00004895]Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction [clinicaltrials:NCT00004910]DX-8951f in Treating Patients With Biliary Cancer [clinicaltrials:NCT00005938]clinicaltrials:NCT00005997clinicaltrials:NCT00009893Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct [clinicaltrials:NCT00010088]Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract [clinicaltrials:NCT00012246]Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [clinicaltrials:NCT00019474]Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas [clinicaltrials:NCT00019513]Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor [clinicaltrials:NCT00021047]Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer [clinicaltrials:NCT00030511]clinicaltrials:NCT00033540clinicaltrials:NCT00059865Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer [clinicaltrials:NCT00073905]Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder [clinicaltrials:NCT00084942]clinicaltrials:NCT00262769clinicaltrials:NCT00266097clinicaltrials:NCT00304135Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer [clinicaltrials:NCT00363584]clinicaltrials:NCT00387348clinicaltrials:NCT00486356clinicaltrials:NCT00513539Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer [clinicaltrials:NCT00544193]Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer [clinicaltrials:NCT00559598]Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer [clinicaltrials:NCT00588263]Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer [clinicaltrials:NCT00654160]Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Biliary Cancer [clinicaltrials:NCT00658593]clinicaltrials:NCT00789958clinicaltrials:NCT00832637Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer [clinicaltrials:NCT00836992]clinicaltrials:NCT00903396clinicaltrials:NCT00919061clinicaltrials:NCT00987766Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery [clinicaltrials:NCT01313377]
condition [clinicaltrials_vocabulary:condition]
Extrahepatic Bile Duct Cancer [clinicaltrials_resource:2afb235bda23dfa1a954074da411145c]
Bio2RDF identifier
2afb235bda23dfa1a954074da411145c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2afb235bda23dfa1a954074da411145c
identifier
clinicaltrials_resource:2afb235bda23dfa1a954074da411145c
title
Extrahepatic Bile Duct Cancer
@en
label
Extrahepatic Bile Duct Cancer [clinicaltrials_resource:2afb235bda23dfa1a954074da411145c]
@en